TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine
- Conditions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2005-09-13
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 36
- Registration Number
- NCT00023387
- Locations
- ๐บ๐ธ
LA County/USC Medical Center, Los Angeles, California, United States
๐บ๐ธChicago VA Medical Center (Lakeside), Chicago, Illinois, United States
๐บ๐ธJohns Hopkins University School of Medicine, Baltimore, Maryland, United States
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
- Conditions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2005-09-05
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 1000
- Registration Number
- NCT00023335
- Locations
- ๐บ๐ธ
LA County/USC Medical Center, Los Angeles, California, United States
๐บ๐ธUniversity of California, San Francisco, San Francisco, California, United States
๐บ๐ธChicago VA Medical Center (Lakeside), Chicago, Illinois, United States
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
- Conditions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2005-09-05
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 20
- Registration Number
- NCT00023400
- Locations
- ๐จ๐ฆ
University of British Columbia, Vancouver, British Columbia, Canada
๐บ๐ธLA County/USC Medical Center, Los Angeles, California, United States
๐บ๐ธJohns Hopkins University School of Medicine, Baltimore, Maryland, United States
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
- Conditions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2005-09-05
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 215
- Registration Number
- NCT00023361
- Locations
- ๐บ๐ธ
Seattle King County Health Department, Seattle, Washington, United States
๐บ๐ธLA County/USC Medical Center, Los Angeles, California, United States
๐บ๐ธUniversity of California, San Francisco, San Francisco, California, United States
TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment
- Conditions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 300
- Registration Number
- NCT00023439
- Locations
- ๐บ๐ธ
University of California, San Francisco, San Francisco, California, United States
๐บ๐ฌMakerere University Medical School, Kampala, Uganda
๐บ๐ธDenver Department of Public Health and Hospitals, Denver, Colorado, United States
Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
- Conditions
- Interventions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 8053
- Registration Number
- NCT00023452
- Locations
- ๐บ๐ธ
Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States
๐บ๐ธMichael Debakey Veterans Affairs Medical Center, Houston, Texas, United States
๐บ๐ธSeattle King County Health Department, Seattle, Washington, United States
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
- Conditions
- Interventions
- First Posted Date
- 2001-09-10
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 98
- Registration Number
- NCT00023374
- Locations
- ๐บ๐ธ
New York University School of Medicine, New York, New York, United States
๐จ๐ฆUniversity of British Columbia, Vancouver, British Columbia, Canada
๐บ๐ธWashington, D.C. VAMC, Washington, District of Columbia, United States